INDUSTRY NEWS
China Absorbent Hygiene Products Expo,China Feminine Care Products Exрo- 2025-12
02
Jiangxi OK Science and Technology Achieved an Operating Revenue of Approximately RMB 737 Million in the First Three Quarters of 2025, a Year-on-Year Surge of 128.50%
Jiangxi OK Science and Technology Achieved an Operating Revenue of Approximately RMB 737 Million in the First Three Quarters of 2025, a Year-on-Year Surge of 128.50% Jiangxi OK Science and Technology Co., Ltd. recorded an operating revenue of approximately RMB 737 million in the first three quarters of 2025, representing a year-on-year increase of 128.50%. The net profit attributable to shareholders of the listed company was about RMB 91.9641 million, with a year-on-year growth of 57.73%. - 2025-12
02
Hangzhou Nbond Nonwovens Co., Ltd. Achieved an Operating Revenue of Approximately RMB 2.022 Billion in the First Three Quarters of 2025, Representing a year-on-year increase of 29.74%
Hangzhou Nbond Nonwovens Co., Ltd. Achieved an Operating Revenue of Approximately RMB 2.022 Billion in the First Three Quarters of 2025, Representing a year-on-year increase of 29.74% Hangzhou Nbond Nonwovens Co., Ltd. recorded an operating revenue of approximately RMB 2.022 billion in the first three quarters of 2025, a year-on-year increase of 29.74%. The net profit attributable to shareholders of the listed company was about RMB 95.9345 million, representing a year-on-year growth of 38.32%. - 2025-12
02
Winner Medical Co., Ltd. Achieved an Operating Revenue of Approximately RMB 2.601 Billion in the Third Quarter of 2025, Representing a year-on-year increase of 27.71%
Winner Medical Co., Ltd. Achieved an Operating Revenue of Approximately RMB 2.601 Billion in the Third Quarter of 2025, Representing a year-on-year increase of 27.71% Winner Medical Co., Ltd. achieved an operating revenue of approximately RMB 2.601 billion in the third quarter of 2025, a year-on-year increase of 27.71%. The net profit attributable to shareholders of the listed company was about RMB 240 million, with a year-on-year growth of 42.11%. - 2025-12
02
Hangzhou Coco Healthcare Products Co., Ltd. Achieved an Operating Revenue of Approximately RMB 829 Million in the First Three Quarters of 2025
Hangzhou Coco Healthcare Products Co., Ltd. Achieved an Operating Revenue of Approximately RMB 829 Million in the First Three Quarters of 2025 Hangzhou Coco Healthcare Products Co., Ltd. achieved an operating revenue of approximately RMB 829 million in the first three quarters of 2025, with a year-on-year increase of 5.12%. The net profit attributable to shareholders of the listed company was about RMB 27.9844 million, representing a year-on-year growth of 26.79%. - 2025-12
02
Tianjin Yiyi Hygiene Products Co., Ltd. Achieved an Operating Revenue of Approximately RMB 1.306 Billion in the First Three Quarters of 2025
Tianjin Yiyi Hygiene Products Co., Ltd. Achieved an Operating Revenue of Approximately RMB 1.306 Billion in the First Three Quarters of 2025 Tianjin Yiyi Hygiene Products Co., Ltd. achieved an operating revenue of approximately RMB 1.306 billion in the first three quarters of 2025, a year-on-year decrease of 0.72%. The net profit attributable to shareholders of the listed company was about RMB 157 million, with a year-on-year increase of 3.82%. - 2025-12
02
C&S Paper Achieved an Operating Revenue of Approximately RMB 6.478 Billion in the First Three Quarters of 2025, Representing a year-on-year increase of 8.78%
C&S Paper Achieved an Operating Revenue of Approximately RMB 6.478 Billion in the First Three Quarters of 2025, Representing a year-on-year increase of 8.78% C&S Paper achieved an operating revenue of approximately RMB 6.478 billion in the first three quarters of 2025, representing a year-on-year increase of 8.78%. The net profit attributable to shareholders of the listed company was about RMB 230 million, with a year-on-year growth of 329.59%. - 2025-11
04
Tongling Jyair Bio-Tech Co., Ltd. Achieved an Operating Revenue of Approximately RMB 255 Million, Representing a year-on-year Increase of 107.21%
Tongling Jyair Bio-Tech Co., Ltd. Achieved an Operating Revenue of Approximately RMB 255 Million, Representing a year-on-year Increase of 107.21% Tongling Jyair Bio-Tech Co., Ltd. achieved operating revenue of approximately RMB 255 million in the third quarter of 2025, a year-on-year increase of 107.21%. Its net profit attributable to shareholders of the listed company was about RMB 35.3194 million, with a year-on-year increase of 336.33%. The growth in operating revenue is mainly due to the increase in orders from overseas customers.
电话：010-64778188 
Email：cidpex@cnppri.com
公众微信号